Very late relapse of Hodgkin's disease: a report of five patients.
The majority of patients with Hodgkin's disease can be cured with current treatment modalities. Relapses beyond 3 years are rare; however, the outcome for patients in late relapse with standard-dose salvage therapy is excellent. In this article, we report five patients who had such relapses and describe their outcome.
Shihabi
S
S
University of Pittsburgh Cancer Institute and UPMC Shadyside Hospital, Pittsburgh, Pennsylvania 15232, USA.
Deutsch
M
M
Jacobs
S A
SA
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000532:radiotherapy*; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D016879:Salvage Therapy